Irina is a member of the Practice Area Patents Technology and Life Sciences and the Life Science & Healthcare Industry Group. She advises national and international pharmaceutical and medical device companies on regulatory aspects and industry-specific agreements.

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

R&D Collaborations | Coffee Break Life Sciences Start-ups #4

2024年4月18日
In-depth analysis

作者 Dr. Stefanie Greifeneder 以及 Irina Rebin

点击此处了解更多
酒店与休闲

Germany as a location for pharmaceutical businesses - quo vadis, 2024?

Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany

2024年1月11日
In-depth analysis

作者 Dr. Manja Epping 以及 Irina Rebin

点击此处了解更多
专利与创新

JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”

2023年10月27日

作者

点击此处了解更多
商业和消费者合同

The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements

2023年9月21日
In-depth analysis

作者 Dr. Manja Epping 以及 Irina Rebin

点击此处了解更多

与我会面:

11月20日

10:00 - 10:30

网络研讨会

Regulatory peculiarities: AI used in medical devices, combination products and companion diagnostics | Coffee Break Life Sciences Start-ups #11

更多